Medication Error Rate Above 5% Due to Improper Midodrine and Ophthalmic Administration
Summary
The facility failed to maintain a medication error rate below 5%, with surveyors identifying an 11.11% error rate based on 3 errors out of 27 medication administration opportunities observed. One deficiency involved a resident with dementia, hearing loss, and hypotension whose care plan included hypotension management with medications as ordered and monitoring for side effects and effectiveness. The resident had an order for Midodrine 10 mg PO three times daily, but there was no corresponding order to check blood pressure prior to administration. During an observed medication pass, a certified medication technician (CMT) administered Midodrine without taking the resident’s blood pressure beforehand and stated they did not know what Midodrine was used for, later acknowledging they should have taken the blood pressure first. Another deficiency involved improper administration of ophthalmic medications to a resident with severely impaired cognition, maximal ADL assistance needs, and diagnoses including kidney disease, hypertension, Alzheimer’s disease, aphasia, and seizures. The resident had physician orders for Dorzolamide HCl-Timolol ophthalmic solution and Brimonidine Tartrate ophthalmic solution, both to be instilled in both eyes three times daily for glaucoma/ocular pressure, but the resident’s care plan did not address the need or reason for eye drops. The facility’s eye drop administration policy required specific technique, including forming a pouch in the lower eyelid, avoiding contact of the dropper tip with the eye, compressing the tear duct or keeping the eye closed, wiping excess solution, and waiting 10 minutes between different eye medications. During an observed eye drop administration, the same CMT pried the resident’s eyelids open while the resident resisted and instilled Brimonidine solution in both eyes, then immediately proceeded to administer Dorzolamide-Timolol solution without pausing between the two different medications. This technique did not follow the facility’s eye drop administration policy or the manufacturer’s instructions, which required a waiting period between different ophthalmic solutions. The DON stated an expectation that staff follow the eye drop administration policy, including hand hygiene, glove use, proper eyelid positioning, wiping excess solution, and pausing between different eye solutions.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.